🇺🇸 FDA
Pipeline program

Percutaneous Transluminal Angioplasty (PTA)

ZKSJ0127

Unknown other active

Quick answer

Percutaneous Transluminal Angioplasty (PTA) for Peripheral Artery Disease is a Unknown program (other) at Black Diamond Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Black Diamond Therapeutics
Indication
Peripheral Artery Disease
Phase
Unknown
Modality
other
Status
active

Clinical trials